US4792549A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Composition of amino acids
Assignee: Morinaga Milk Industry Co Ltd
•
Filing: 1986-12-24
•
Granted: 1988-12-20
•
Expires: 2006-12-24
Abstract
Abstract A composition of amino acids which can be orally administrated to patients of hepatic and renal diseases for increasing serum albumin, haemoglobin and branched amino acids in serum and for improving nitrogen metabolism and which comprises 32.0 weight parts of amino acid selected from the group consisting of cystine, cysteine, methionine and a mixture thereof, 14.0-20.7 weight parts of alanine, 18.7-28.0 weight parts of aspartic acid and 15.5-23.4 weight parts of glycine in 100 weight parts of total amino acids contents in the final product.
Inventors
- 👤 Akira Takahashi
- 👤 Yoshiyuki Shimamura
- 👤 Hide Kobayashi
- 👤 Shigeo Okonogi
- 👤 Takuji Kawashima
- 👤 Minoru Igarashi
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 23:56
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/01; A61P; A61P1/00; A61P1/16; A61P13/00; A61P13/02; A61P15/00; A61P3/00
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
52 words
An amino acid-containing composition suitable for oral administration to patients having hepatic and renal diseases, which consists essentially of glycine, alanine, aspartic acid and an amino acid selected from the group consisting of cystine, cysteine, methionine and a mixture thereof in a ratio of 0.5:0.4:0.6:1 by weight part in the final product.
Claim 2
Dependent Claim
52 words
An amino acid-containing composition suitable for oral administration to patients having hepatic and renal diseases, which consists essentially of glycine, alanine, aspartic acid and an amino acid selected from the group consisting of cystine, cysteine, methionine and a mixture thereof in a ratio of 0.5:0.4:0.6:1 by weight part in the final product.
Claim 3
Dependent Claim
18 words
The amino acid-containing composition of claim 1, wherein said amino acid is cystine, cysteine or a mixture thereof.
References Cited (Backward Citations)
US3950529A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-12-20 | 1992-06-20 | 1992-12-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-12-20 | 1996-06-20 | 1996-12-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-12-20 | 2000-06-20 | 2000-12-20 | $7700.00 | Window Closed / Lapsed |